Brooks Laboratories Ltd. IPO

Brooks Laboratories Ltd. is listed in the MAINBOARD segment. The figures below are as reported by the exchanges and public sources.

Brooks Laboratories Ltd. IPO — key facts

• As of 6 September 2026, the Brooks Laboratories Ltd. IPO subscription status is 1.60x overall.
• The issue is open from 16-Aug-2011 to 18-Aug-2011.
• Brooks Laboratories Ltd. listed on 05-Sep-2011.
• Brooks Laboratories Ltd. listed at ₹61.5. The listing loss was 38.5% against the upper end of the issue price band.

Brooks Laboratories Ltd. IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price

₹100

Issue size

₹63 Cr

Fresh issue

₹63 Cr

Opens

16-Aug-2011

Closes

18-Aug-2011

Listing

05-Sep-2011

Total subscription

1.60x

Retail

3.36x

NII

2.82x

Lead managers

D&A Financial

Listing price

₹61.5

Listing day change

-38.5%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.